These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8620621)

  • 1. Tenfold increased incidence of spontaneous multiple myeloma in long-term immunosuppressed aging C57BL/KaLwRij mice.
    Radl J; Van Arkel C; Hopstaken CM; HogenEsch H
    Clin Immunol Immunopathol; 1996 May; 79(2):155-62. PubMed ID: 8620621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma and related disorders. Lessons from an animal model.
    Radl J
    Pathol Biol (Paris); 1999 Feb; 47(2):109-14. PubMed ID: 10192877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic paraproteinaemia. I. Studies in an animal model--the ageing C57BL/KaLwRij mouse.
    Radl J; Hollander CF; van den Berg P; de Glopper E
    Clin Exp Immunol; 1978 Sep; 33(3):395-402. PubMed ID: 367647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of clonal dominance in the specific antibody response to DNP-HSA in CBA and C57BL mice reflects their susceptibility to age-associated development of monoclonal gammopathies.
    van Arkel C; Nooij FJ; van der Sluijs-Gelling AJ; Radl J
    Clin Immunol Immunopathol; 1997 Jun; 83(3):272-80. PubMed ID: 9175916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse.
    Manning LS; Berger JD; O'Donoghue HL; Sheridan GN; Claringbold PG; Turner JH
    Br J Cancer; 1992 Dec; 66(6):1088-93. PubMed ID: 1457349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of genetic factors associated with the immunoglobulin heavy chain locus on the development of benign monoclonal gammapathy in ageing IgH-congenic mice.
    van den Akker TW; de Glopper-van der Veer E; Radl J; Benner R
    Immunology; 1988 Sep; 65(1):31-5. PubMed ID: 3141270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging and proliferative homeostasis: monoclonal gammopathies in mice and men.
    Radl J
    Lab Anim Sci; 1992 Apr; 42(2):138-41. PubMed ID: 1318444
    [No Abstract]   [Full Text] [Related]  

  • 8. Idiopathic paraproteinemia. III. Increased frequency of paraproteinemia in thymectomized aging C57BL/KaLwRij and CBA/BrARij mice.
    Radl J; de Glopper E; van den Berg P; van Zwieten MJ
    J Immunol; 1980 Jul; 125(1):31-5. PubMed ID: 6769998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types.
    Amend SR; Wilson WC; Chu L; Lu L; Liu P; Serie D; Su X; Xu Y; Wang D; Gramolini A; Wen XY; O'Neal J; Hurchla M; Vachon CM; Colditz G; Vij R; Weilbaecher KN; Tomasson MH
    PLoS One; 2015; 10(5):e0127828. PubMed ID: 26020268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune regulation of mouse 5T2 multiple myeloma. I. Immune response to 5T2 MM idiotype.
    Croese JW; Vissinga CS; Boersma WJ; Radl J
    Neoplasma; 1991; 38(5):457-66. PubMed ID: 1956463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of H-2 genetic factors on the development of benign monoclonal gammopathy in ageing H-2 congenic C57BL and BALB mice.
    van den Akker TW; Tio-Gillen AP; Benner R; Zurcher C; Radl J
    Immunology; 1987 Aug; 61(4):403-8. PubMed ID: 3443448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 213Bi radioimmunotherapy with an anti-mCD138 monoclonal antibody in a murine model of multiple myeloma.
    Chérel M; Gouard S; Gaschet J; Saï-Maurel C; Bruchertseifer F; Morgenstern A; Bourgeois M; Gestin JF; Bodéré FK; Barbet J; Moreau P; Davodeau F
    J Nucl Med; 2013 Sep; 54(9):1597-604. PubMed ID: 24003167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of 5T33 myeloma cells in the C57BL/KaLwRij mouse: establishment of a new syngeneic murine model of multiple myeloma.
    Alici E; Konstantinidis KV; Aints A; Dilber MS; Abedi-Valugerdi M
    Exp Hematol; 2004 Nov; 32(11):1064-72. PubMed ID: 15539084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial genome of a spontaneous multiple myeloma bone cancer model mouse C57BL/KaLwRij strain.
    Liu ZG; Tang B; Zeng Y; He N; Wang ZY; Han H; Wang L; Wang TZ; Yu HL; Xiong M
    Mitochondrial DNA A DNA Mapp Seq Anal; 2016 Nov; 27(6):4071-4072. PubMed ID: 25693717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of renal lesions in C57BL/KaLwRij mice with advanced myeloma due to 5T2MM cells.
    Libouban H; Onno C; Pascaretti-Grizon F; Gallois Y; Moreau MF; Baslé MF; Chappard D
    Leuk Res; 2006 Nov; 30(11):1371-5. PubMed ID: 16814861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse plasmacytoma: an experimental model of human multiple myeloma.
    Gadó K; Silva S; Pálóczi K; Domján G; Falus A
    Haematologica; 2001 Mar; 86(3):227-36. PubMed ID: 11255268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum protein immunofixation in malignant hemopathies other than multiple myeloma and Waldenstrom's macroglobulinemia].
    Ramont L; Ngoc PT; Pignon B; Maquart FX
    Ann Biol Clin (Paris); 2002; 60(5):565-70. PubMed ID: 12368142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic paraproteinaemia. IV. The role of genetic factors in the development of monoclonal B cell proliferative disorders--a study in the ageing C57BL/KaLwRij and CBA/BrARij mouse radiation chimeras.
    Radl J; Heidt PJ; Knaan-Shanzer S; van Zwieten MJ
    Clin Exp Immunol; 1984 Oct; 58(1):213-6. PubMed ID: 6383667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels.
    Yadav P; Merz M; Mai EK; Försti A; Jauch A; Goldschmidt H; Hemminki K
    Haematologica; 2018 Apr; 103(4):e162-e164. PubMed ID: 29419430
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.
    Jimenez-Zepeda VH; Heilman RL; Engel RA; Carey EJ; Freeman C; Rakela J; Mulligan DC; Fonseca R; Stewart AK
    Transplantation; 2011 Sep; 92(5):570-4. PubMed ID: 21712755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.